Neurologists’ preferences for device-aided therapy for advanced Parkinson’s disease in Japan
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2129800
Abstract: Abstract Objective This study measures the relative preference for attributes of device-aided therapies (DATs) for advanced Parkinson’s Disease (PD) from the perspective of Japanese neurologists. Methods Attributes and levels were elicited based on literature and… read more here.
Keywords: device aided; parkinson disease; device; advanced parkinson ... See more keywords
Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Parkinson's Disease"
DOI: 10.3233/jpd-202348
Abstract: Background: Despite optimal dopaminergic treatment most patients in moderate to advanced stages of Parkinson’s disease (PD) experience progressively increasing disabilities, necessitating a shift from oral medication to device-aided therapies, including deep brain stimulation (DBS), intrajejunal… read more here.
Keywords: parkinson disease; device aided; aided therapies; cost effectiveness ... See more keywords
A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Parkinson's Disease"
DOI: 10.3233/jpd-212986
Abstract: Parkinson’s disease (PD) is in some cases predisposed-or-caused by genetic variants, contributing to the expression of different phenotypes. Regardless of etiology, as the disease progresses, motor fluctuations and/or levodopa-induced dyskinesias limit the benefit of pharmacotherapy.… read more here.
Keywords: device aided; response device; aided therapies; disease ... See more keywords
The Role of Genetic Data in Selecting Device-Aided Therapies in Patients With Advanced Parkinson’s Disease: A Mini-Review
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Aging Neuroscience"
DOI: 10.3389/fnagi.2022.895430
Abstract: Parkinson’s disease (PD) is a common neurodegenerative disease. At present, 5–10% of PD patients are found to have monogenic form of the disease. Each genetic mutation has its own unique clinical features and disease trajectory.… read more here.
Keywords: outcome; disease; device aided; parkinson disease ... See more keywords